The Speed of Trust by Stephen M.R. Covey


The Magnificent Seven


Crosby, Stills & Nash; Van Morrison; Mumford and Sons; Red Hot Chili Peppers 


"As I grow older, I pay less attention to what men say. I just watch what they do." - Andrew Carnegie


John McIlwraith

Managing Director



John co-founded Allos in 2010, but he did some pretty cool stuff before that, too. He was also a lawyer.

John started his career as a corporate lawyer at Jones Day, where he co-founded the Private Ventures Group after determining that the firm needed a better way to serve the needs of entrepreneurs, venture capital, and private equity investors. After several years of representing VC firms, like Primus and Morgenthaler, and early-stage technology companies, he decided he was envious of how much fun his clients were having and that he wanted to go down a more entrepreneurial path.

Although he achieved success as an attorney, he knew that to succeed as a venture capitalist he would need operating experience.  So, he joined publicly-traded Quantum Health Resources, a provider of drugs and related therapies to patients with rare, chronic diseases, as SVP of business development and general counsel.  In 1997, after Quantum was sold to Olsten Health Services (where John continued on as SVP of business development), he was recruited to Blue Chip Venture Company.

John’s investment experience includes software, business services, and healthcare technology companies such as Assurex Health (sold to Myriad Genetics), Bluegill Technologies (sold to Checkfree), Inspiris (sold to United Healthcare), Medhost (sold to HealthTech Holdings), Healthscribe (sold to Spheris), and Renal Solutions (sold to Fresenius).

John has been involved in a variety of early-stage venture initiatives throughout the Midwest. He was active in the formation of Gazelle TechVentures, where he met Don. He was also a founding member of the Michigan Venture Capital Association board of directors, and was the founding chairman of VentureOhio.  And he is a founding board member of OCEAN Accelerator.  John is also a member of the board of directors of publicly-traded Meridian Bioscience.  

JD, Case Western Reserve University
BA, Hillsdale College